Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM).

Tumori - 1 Apr 2021

Gadducci Angiolo, Aletti Giovanni D, Landoni Fabio, Lazzari Roberta, Mangili Giorgia, Olivas Paola, Pignata Sandro, Salutari Vanda, Sartori Enrico, Scambia Giovanni, Zannoni Gian Franco, Sabbatini Roberto, Lorusso Domenica

Abstract excerpt

INTRODUCTION: Ovarian cancer is the most lethal gynecologic malignancy. Over 5200 new cases of this tumor are diagnosed yearly in Italy, resulting in more than 3600 deaths. In terms of molecular biology, five different ovarian cancer subtypes should be distinguished. METHOD: This article summarizes the evidence-based guidelines that the Italian Medical Oncology Association (AIOM) has developed with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Bevacizumab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Medical Oncology

Share to Neoplasm Recurrence, Local

Share to Poly(ADP-ribose) Polymerase Inhibitors

Share to Practice Guidelines as Topic

Source

Identifiers

PMID: 33106117
DOI: 10.1177/0300891620966382

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM).PMID 33106117Read ↗

[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].Semantic proximity Read ↗

PARP Inhibitors in the Management of Ovarian Cancer: ASCO GuidelineSemantic proximity Read ↗

Ovarian cancer: emerging molecular-targeted therapiesSemantic proximity Read ↗

Wise Management of Ovarian Cancer: On the Cutting EdgeSemantic proximity Read ↗

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Semantic proximity Read ↗

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).Semantic proximity Read ↗

Diagnosis and Management of Ovarian Cancer.Semantic proximity Read ↗

Ovarian Cancer: Many Diseases Under One Name.Semantic proximity Read ↗

Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing TherapySemantic proximity Read ↗

[BRCA diagnostics of ovarian cancer : Molecular tumor testing since the introduction of PARP inhibitor therapy].Semantic proximity Read ↗

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity Read ↗

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.